Current state of evidence on „off-label“ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report - Aringer, M; Burkhardt, H; Burmester, G R (Lupus, 2012)
et al.